placebo + ezetimibe

This is a combination of a placebo and ezetimibe. Ezetimibe is a selective cholesterol absorption inhibitor used to lower blood cholesterol levels, particularly low-density lipoprotein (LDL) cholesterol. It works by inhibiting the absorption of cholesterol at the brush border of the small intestine, primarily through blocking the Niemann-Pick C1-Like 1 (NPC1L1) protein, which reduces intestinal uptake of dietary and biliary cholesterol. Placebo is an inert substance with no pharmacological effect, often used as a control in clinical trials. This combination may be used in research settings to compare the effects of ezetimibe against an inactive control[1][3][4][5].